A2 Vertaisarvioitu katsausartikkeli tieteellisessä lehdessä

Harnessing nanoparticles for phytochemical delivery: a comprehensive review of safety and therapeutic potential




TekijätOladipupo, Sharon; Rotimi, Damilare Emmanuel; Ezenabor, Emmanuel Henry; Ojo, Adebola Busola; Akinsola, Oluwatomisin Aderonke; Ojo, Oluwafemi Adeleke

KustantajaTaylor & Francis

Julkaisuvuosi2025

Lehti:Therapeutic Delivery

ISSN2041-5990

eISSN2041-6008

DOIhttps://doi.org/10.1080/20415990.2025.2570638

Verkko-osoitehttps://doi.org/10.1080/20415990.2025.2570638

Rinnakkaistallenteen osoitehttps://research.utu.fi/converis/portal/detail/Publication/504672707


Tiivistelmä

Nanoparticle encapsulation has emerged as a relevant technology with the potential to revolutionize multiple fields, including medicine, food technology, cosmetics, and environmental monitoring. This review discusses the fundamental aspects of nanoparticle encapsulation, highlighting its benefits, such as enhanced solubility, stability, and bioavailability of phytochemicals. The data for this report were obtained via an extensive review of the peer-reviewed scientific literature. We reviewed various types of nanoparticles used in encapsulation, the efficacy of nanoparticle-encapsulated phytochemicals, and the challenges faced, including formulation complexity and regulatory hurdles. The review also considers current and future applications, providing examples of how advanced technologies such as artificial intelligence and novel manufacturing methods contribute to innovation in this field. As nanoparticle technology progresses, addressing safety and regulatory issues will be critical for its successful integration and commercialization. This review underscores the promising future of nanoparticle technology.


Ladattava julkaisu

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.




Julkaisussa olevat rahoitustiedot
Dr. Oluwafemi Ojo has been co-funded by the European Union’s Horizon Europe Framework Programme for Research and Innovation 2021–2027 under the Marie Sklodowska-Curie action grant agreement No. 101126611.


Last updated on 2025-04-11 at 13:18